MARKET

CORT

CORT

Corcept Therapeutics Inc
NASDAQ
79.37
-4.44
-5.30%
After Hours: 80.25 +0.88 +1.11% 19:59 04/03 EDT
OPEN
79.16
PREV CLOSE
83.81
HIGH
82.96
LOW
77.01
VOLUME
2.09M
TURNOVER
--
52 WEEK HIGH
117.33
52 WEEK LOW
20.84
MARKET CAP
8.37B
P/E (TTM)
63.78
1D
5D
1M
3M
1Y
5Y
1D
DNLI Begins Rolling BLA Submission for Hunter Syndrome Drug, Stock Up
NASDAQ · 11h ago
NRIX Stock Up as SNY In-Licenses Rights to Autoimmune Diseases Program
NASDAQ · 11h ago
Corcept Therapeutics Is Maintained at Overweight by Piper Sandler
Dow Jones · 11h ago
Piper Sandler Maintains Overweight on Corcept Therapeutics, Raises Price Target to $131
Benzinga · 11h ago
Corcept Therapeutics price target raised to $131 from $128 at Piper Sandler
TipRanks · 14h ago
Biotech Stock Roundup: CORT Up on Study Data, Updates From AXSM, BMY, EXEL & More
NASDAQ · 1d ago
Biotech Alert: Searches spiking for these stocks today
TipRanks · 1d ago
Does Corcept (CORT) Have the Potential to Rally 28.63% as Wall Street Analysts Expect?
NASDAQ · 1d ago
More
About CORT
More
Corcept Therapeutics Incorporated is a commercial-stage company. The Company is engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. The Company operates through the discovery, development and commercialization of the pharmaceutical products segment. The Company has marketed Korlym (mifepristone) in the United States for the treatment of patients suffering from Cushings syndrome. The Company’s portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. Its portfolio of selective cortisol modulators consists of relacorilant, dazucorilant and miricorilant. Korlyms active ingredient, mifepristone, reduces the binding of excess cortisol to the GR, it can modulate the effects of abnormal levels and release patterns of cortisol without compromising cortisols healthy functions and rhythms.
Recently
Symbol
Price
%Change

Webull offers Corcept Therapeutics Inc stock information, including NASDAQ: CORT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CORT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CORT stock methods without spending real money on the virtual paper trading platform.